Effects of the Application of PIOMI in the Oral Feeding of Premature

NCT06395298 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 35

Last updated 2024-05-02

No results posted yet for this study

Summary

The goal of this clinical trial is assess whether the application of the premature oral motor intervention (PIOMI) combined with the Newborn Individualized Developmental Care and Assessment Program (NIDCAP), allows withdrawal of the external feeding device with guarantees of the patient's nutritional status, determining breastfeeding rates at hospital discharge and swallowing safety earlier than if only the care activity corresponding to the NIDCAP model is carried out, as well as the applicability of this standardised protocol in the neonatal intensive care unit of a tertiary hospital.

Conditions

  • Dysphagia
  • Disorder; Feeding, Newborn
  • Premature

Interventions

OTHER

Experimental group PIOMI

A group treated with the application of the care model Newborn Individualized Development Care and Assessment Program (NIDCAP) in the Neonatal Intensive Unit Care (NICU)+PIOMI

OTHER

Control group NIDCAP

A group treated with the application of the care model Newborn Individualized Development Care and Assessment Program (NIDCAP) in the Neonatal Intensive Unit Care (NICU)

Sponsors & Collaborators

  • Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition

    collaborator UNKNOWN
  • Nexe Foundation

    collaborator UNKNOWN
  • University Ramon Llull

    collaborator OTHER
  • Borja Institute of Bioethics

    collaborator UNKNOWN
  • Institut de Recerca Sant Joan de Déu

    collaborator UNKNOWN
  • Fundació Sant Joan de Déu

    lead OTHER

Principal Investigators

  • Raquel García Ezquerra · Sant Joan de Déu Hospital

  • Vanesa Ejarque Marin · Sant Joan de Déu Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
29 Weeks
Max Age
30 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-13
Primary Completion
2026-06-03
Completion
2026-12-30

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06395298 on ClinicalTrials.gov